Introduction Of Long-Acting Injectable Cabotegravir PrEP May Reduce AIDS Deaths, Infections In Sub-Saharan Africa, Study Suggests

January 24, 2023

Healio (1/23, Stulpin) reports, “The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future AIDS deaths and new infections, while being a cost-effective alternative to oral PrEP, according to a...study....